These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32877311)

  • 61. Cardiac extracellular matrix tenascin-C deposition during fibronectin degradation.
    Ma S; Yang D; Li D; Tang B; Sun M; Yang Y
    Biochem Biophys Res Commun; 2011 Jun; 409(2):321-7. PubMed ID: 21586275
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Type III and V collagens modulate the expression and assembly of EDA(+) fibronectin in the extracellular matrix of defective Ehlers-Danlos syndrome fibroblasts.
    Zoppi N; Ritelli M; Colombi M
    Biochim Biophys Acta; 2012 Oct; 1820(10):1576-87. PubMed ID: 22705941
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Modulation of urokinase-type and tissue-type plasminogen activator occurs at an early stage of progressing stages of chronic venous insufficiency.
    Peschen M; Rogers AA; Chen WY; Vanscheidt W
    Acta Derm Venereol; 2000 May; 80(3):162-6. PubMed ID: 10954203
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Acute lipodermatosclerosis is associated with venous insufficiency.
    Greenberg AS; Hasan A; Montalvo BM; Falabella A; Falanga V
    J Am Acad Dermatol; 1996 Oct; 35(4):566-8. PubMed ID: 8859285
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tenascin-C degradation in chronic wounds is dependent on serine proteinase activity.
    Latijnhouwers MA; Bergers M; Veenhuis RT; Beekman B; Ankersmit-Ter Horst MF; Schalkwijk J
    Arch Dermatol Res; 1998 Sep; 290(9):490-6. PubMed ID: 9808342
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Production of fibronectin and tenascin isoforms and their role in the adhesion of human immortalized corneal epithelial cells.
    Filenius S; Tervo T; Virtanen I
    Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3317-25. PubMed ID: 12882776
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Venous disorders: treatment with sclerosant foam.
    Bergan J; Pascarella L; Mekenas L
    J Cardiovasc Surg (Torino); 2006 Feb; 47(1):9-18. PubMed ID: 16434941
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts.
    Tremble P; Chiquet-Ehrismann R; Werb Z
    Mol Biol Cell; 1994 Apr; 5(4):439-53. PubMed ID: 7519905
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Correlation of the anatomical distribution of venous reflux with clinical symptoms and venous haemodynamics in primary varicose veins.
    Sakurai T; Gupta PC; Matsushita M; Nishikimi N; Nimura Y
    Br J Surg; 1998 Feb; 85(2):213-6. PubMed ID: 9501819
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.
    Chen Y; Peng W; Raffetto JD; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():267-299. PubMed ID: 28413031
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Varicose veins and chronic venous insufficiency.
    Partsch H
    Vasa; 2009 Nov; 38(4):293-301. PubMed ID: 19998250
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The systemic anatomy of the perforating veins in the leg, especially Cockett's veins.
    van Limborgh J; Hage RW
    Phlebologie; 1982; 35(1):19-28. PubMed ID: 7071171
    [No Abstract]   [Full Text] [Related]  

  • 73. ICVTS on-line discussion A. Valves and primary varicose veins.
    Hudorovic N
    Interact Cardiovasc Thorac Surg; 2007 Apr; 6(2):224. PubMed ID: 17669816
    [No Abstract]   [Full Text] [Related]  

  • 74. [Chronic venous insufficiency. Results of duplex scanning of 205 lower extremities with varices: 106 not previously operated and 99 previously operated for varicose veins].
    Egeblad K; Baekgaard N
    Ugeskr Laeger; 2003 Jul; 165(31):3016-8. PubMed ID: 12938295
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular Mechanism Responsible for Fibronectin-controlled Alterations in Matrix Stiffness in Advanced Chronic Liver Fibrogenesis.
    Iwasaki A; Sakai K; Moriya K; Sasaki T; Keene DR; Akhtar R; Miyazono T; Yasumura S; Watanabe M; Morishita S; Sakai T
    J Biol Chem; 2016 Jan; 291(1):72-88. PubMed ID: 26553870
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Method of studying the venous system in patients with venous diseases of the lower limbs].
    Dukhieva LI; Sergeeva KA; Kolesnikova RS
    Klin Med (Mosk); 1981 Nov; 59(11):85-7. PubMed ID: 7321506
    [No Abstract]   [Full Text] [Related]  

  • 77. [Assessment of the functional capacity in the patients with venous diseases].
    Voigt H; Hackel F; Wiemers U
    Z Gesamte Inn Med; 1975 Nov; 30(21):230-3. PubMed ID: 1210464
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The interplay of fibronectin functionalization and TGF-β1 presence on fibroblast proliferation, differentiation and migration in 3D matrices.
    Sapudom J; Rubner S; Martin S; Thoenes S; Anderegg U; Pompe T
    Biomater Sci; 2015 Sep; 3(9):1291-301. PubMed ID: 26230292
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The interaction of tenascin-C with fibronectin modulates the migration and specific metalloprotease activity in human mesothelioma cell lines of different histotype.
    Giuffrida A; Scarpa S; Birarelli P; Modesti A
    Int J Oncol; 2004 Sep; 25(3):745-50. PubMed ID: 15289878
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Venous insufficiency].
    Suñé Ysamat B
    Rev Enferm; 1985 Jun; 8(83):82-5. PubMed ID: 3848068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.